Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $21.7B
- 77 holdings
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
AUM over time
Book
| IQV, IQVIA | Reduce −0.2% | 3,207,582 | $181.14 | $581M | −6,000 | −$116M | |
| TMO, Thermo Fisher Scientific | Reduce −9.7% | 1,122,059 | $507.19 | $569M | −120,400 | −$106M | |
| Change Healthcare | New | 18,076,272 | $27.49 | $497M | +18,076,272 | +$497M | |
| ARMK, Aramark | Reduce −0.5% | 15,921,642 | $31.20 | $497M | −86,375 | +$6.4M | |
| BSX, Boston Scientific | Reduce −19.2% | 12,151,257 | $38.73 | $471M | −2,896,000 | −$90M | |
| TRU, Transunion | Add +6.0% | 7,907,895 | $59.49 | $470M | +444,899 | −$127M | |
| CLVT, Clarivate | Add +65.1% | 40,546,300 | $9.39 | $381M | +15,988,500 | +$40M | |
| ELV, Elevance Health | Reduce −3.0% | 801,400 | $454.24 | $364M | −25,082 | −$35M | |
| New | 7,755,000 | $43.84 | $340M | +7,755,000 | +$340M | ||
| MSFT, Microsoft | Add +13.1% | 1,439,178 | $232.90 | $335M | +166,300 | +$8.3M | |
| CNC, Centene | Reduce −2.1% | 4,252,141 | $77.81 | $331M | −89,053 | −$36M | |
| GOOG, Alphabet | Add +2250.7% | 3,371,140 | $96.15 | $324M | +3,227,733 | +$10M | |
| AZNN | Add +20.6% | 5,584,962 | $54.84 | $306M | +955,000 | +$377K | |
| EFX, Equifax | Add +10.4% | 1,785,097 | $171.43 | $306M | +167,740 | +$10M | |
| HWM, Howmet Aerospace | Reduce −28.9% | 9,842,353 | $30.93 | $304M | −3,995,000 | −$131M | |
| MA, Mastercard | Reduce −7.2% | 1,068,371 | $284.34 | $304M | −82,900 | −$59M | |
| CRM, Salesforce | Add +17.2% | 2,060,938 | $143.84 | $296M | +302,000 | +$6.2M | |
| YMM, Full Truck Alliance | Add +13.8% | 45,164,743 | $6.55 | $296M | +5,489,000 | −$64M | |
| BHVN, Biohaven | New | 1,947,820 | $151.17 | $294M | +1,947,820 | +$294M | |
| WAB, Wabtec | Reduce −12.2% | 3,502,930 | $81.35 | $285M | −487,003 | −$43M | |
| V, Visa | Add +3.4% | 1,512,210 | $177.65 | $269M | +49,400 | −$19M | |
| SHW, Sherwin-Williams | Add +20.4% | 1,279,492 | $204.75 | $262M | +216,900 | +$24M | |
| BX, Blackstone | Add +10.4% | 3,114,951 | $83.70 | $261M | +293,500 | +$3.3M | |
| DT, Dynatrace | Reduce −8.2% | 7,202,000 | $34.81 | $251M | −645,000 | −$59M | |
| META, Meta Platforms | Add +1.5% | 1,807,040 | $135.68 | $245M | +26,000 | −$42M | |
| NYT, New York Times | Add +13.8% | 7,828,073 | $28.75 | $225M | +947,269 | +$33M | |
| SPGI, S&P Global | Add +118.1% | 717,500 | $305.35 | $219M | +388,500 | +$108M | |
| AON, Aon | Reduce −12.9% | 808,486 | $267.87 | $217M | −120,000 | −$34M | |
| CSGP, CoStar Group | Reduce −40.4% | 2,960,185 | $69.65 | $206M | −2,003,000 | −$94M | |
| ADBE, Adobe | Reduce −2.3% | 694,772 | $275.20 | $191M | −16,000 | −$69M | |
| NOW, ServiceNow | Add +0.7% | 493,550 | $377.61 | $186M | +3,400 | −$47M | |
| BEKE, KE Holdings | Hold | 9,958,500 | $17.52 | $174M | — | — | |
| BEAM, Beam Therapeutics | Add +4.6% | 3,631,271 | $47.64 | $173M | +159,000 | +$39M | |
| EXEL, Exelixis | Add +4.9% | 10,675,844 | $15.68 | $167M | +501,571 | −$44M | |
| XYZ, Block | Reduce −9.0% | 2,584,000 | $54.99 | $142M | −255,000 | −$32M | |
| HUM, Humana | New | 251,200 | $485.19 | $122M | +251,200 | +$122M | |
| CVS, CVS Health | Add +0.8% | 1,256,259 | $95.37 | $120M | +10,000 | +$4.3M | |
| UTHR, United Therapeutics | Add +40.0% | 549,673 | $209.38 | $115M | +156,977 | +$23M | |
| Horizon Therapeutics Pub | Add +62.9% | 1,780,223 | $61.89 | $110M | +687,063 | +$110M | |
| ABBV, AbbVie | Add +43.4% | 725,112 | $134.21 | $97M | +219,597 | +$20M | |
| ALNY, Alnylam Pharmaceuticals | Reduce −45.6% | 428,456 | $200.16 | $86M | −359,454 | −$29M | |
| INSP, Inspire Medical Systems | Add +16.7% | 481,996 | $177.37 | $85M | +68,996 | +$10M | |
| Sarepta Therapeutics | Reduce −36.3% | 754,950 | $110.54 | $83M | −430,101 | −$5.4M | |
| BIIB, Biogen | Add +9.7% | 305,499 | $267.00 | $82M | +27,000 | +$25M | |
| Masimo | Add +195.9% | 577,000 | $141.16 | $81M | +382,000 | +$56M | |
| ENTA, Enanta Pharmaceuticals | Hold | 1,550,000 | $51.87 | $80M | — | — | |
| PCG, PG&E | Hold | 6,305,142 | $12.50 | $79M | — | — | |
| CYTK, Cytokinetics | Reduce −27.8% | 1,621,038 | $48.45 | $79M | −624,000 | −$9.7M | |
| AVTR, Avantor | Reduce −30.3% | 3,679,464 | $19.60 | $72M | −1,600,000 | −$92M | |
| JAZZ, Jazz Pharmaceuticals | Reduce −41.6% | 537,500 | $133.29 | $72M | −382,600 | −$72M | |
| Nielsen | New | 2,470,976 | $27.72 | $68M | +2,470,976 | +$68M | |
| Lufax | Reduce −13.5% | 20,536,399 | $2.54 | $52M | −3,204,000 | −$90M | |
| BRKR, Bruker | Reduce −32.9% | 943,800 | $53.06 | $50M | −463,000 | −$38M | |
| RVMD, Revolution Medicines | Reduce −23.1% | 2,500,000 | $19.72 | $49M | −750,000 | −$14M | |
| Laboratory Corporation Amer | Reduce −58.5% | 215,314 | $204.81 | $44M | −303,400 | −$77M | |
| AGIO, Agios Pharmaceuticals | Add +12.3% | 1,496,829 | $28.28 | $42M | +163,817 | +$13M | |
| Chemocentryx | New | 800,000 | $51.66 | $41M | +800,000 | +$41M | |
| Imago Biosciences | Hold | 2,471,313 | $15.05 | $37M | — | — | |
| BABA, Alibaba | New | 464,000 | $79.99 | $37M | +464,000 | +$37M | |
| Catalent | Add +11.0% | 465,755 | $72.36 | $34M | +46,000 | −$11M | |
| APLS, Apellis Pharmaceuticals | New | 478,000 | $68.30 | $33M | +478,000 | +$33M | |
| Ironsource | New | 9,130,000 | $3.44 | $31M | +9,130,000 | +$31M | |
| PTGX, Protagonist Therapeutics | Reduce −1.3% | 3,651,887 | $8.43 | $31M | −48,721 | +$1.5M | |
| Holding | New | 450,000 | $68.10 | $31M | +450,000 | +$31M | |
| Marblegate Acquisition | Hold | 2,970,000 | $9.96 | $30M | — | — | |
| Holding | Hold | 2,809,000 | $9.78 | $27M | — | — | |
| Broadmark Realty Cap | Hold | 4,850,000 | $5.11 | $25M | — | — | |
| Holding | Hold | 2,500,000 | $9.81 | $25M | — | — | |
| Metals Acquisition | Hold | 2,489,700 | $9.81 | $24M | — | — | |
| Berenson Acquisition | Hold | 2,475,000 | $9.84 | $24M | — | — | |
| Iveric Bio | New | 1,317,000 | $17.94 | $24M | +1,317,000 | +$24M | |
| Cara Therapeutics | Hold | 2,500,000 | $9.36 | $23M | — | — | |
| Swiftmerge Acquisition | Hold | 1,980,000 | $9.93 | $20M | — | — | |
| Revolution Healthcar Aq | Hold | 2,000,000 | $9.83 | $20M | — | — | |
| Holding | Hold | 1,900,000 | $9.82 | $19M | — | — | |
| Karuna Therapeutics | Reduce −20.0% | 80,000 | $224.92 | $18M | −20,000 | +$5.3M | |
| Amyris | Reduce −71.1% | 6,126,642 | $2.92 | $18M | −15,083,240 | −$21M | |
| Holding | Hold | 1,732,500 | $9.97 | $17M | — | — | |
| Holding | Hold | 1,750,000 | $9.84 | $17M | — | — | |
| Sdcl Edge Acquisition | Hold | 1,732,500 | $9.89 | $17M | — | — | |
| Vector Acquisition Corporation II | Hold | 1,700,000 | $9.92 | $17M | — | — | |
| Shelter Acquisition | Hold | 1,650,000 | $9.91 | $16M | — | — | |
| Savara | Add +3.5% | 9,908,086 | $1.55 | $15M | +330,813 | +$801K | |
| Big Sky Growth Partners | Hold | 1,550,000 | $9.78 | $15M | — | — | |
| KKR | Hold | 1,500,000 | $9.84 | $15M | — | — | |
| Holding | Hold | 1,500,000 | $9.81 | $15M | — | — | |
| Ares Acquisition | Hold | 1,425,000 | $9.93 | $14M | — | — | |
| Humanco Acquisition | Hold | 1,407,749 | $9.96 | $14M | — | — | |
| Disruptive Acquisition | Hold | 1,400,000 | $9.94 | $14M | — | — | |
| Holding | Hold | 1,360,040 | $9.84 | $13M | — | — | |
| Generation Bio | Reduce −13.7% | 2,500,000 | $5.31 | $13M | −397,300 | −$5.7M | |
| Holding | New | 486,902 | $26.75 | $13M | +486,902 | +$13M | |
| Holding | Hold | 1,250,000 | $9.83 | $12M | — | — | |
| Agile Growth | Hold | 1,200,000 | $9.93 | $12M | — | — | |
| Holding | Hold | 1,208,326 | $9.85 | $12M | — | — | |
| TCV Acquisition | Hold | 1,211,459 | $9.82 | $12M | — | — | |
| Nightdragon Acquisition | Hold | 1,200,000 | $9.82 | $12M | — | — | |
| Gores Holdings VII | Hold | 1,150,162 | $9.86 | $11M | — | — | |
| Tiga Acquisition | Hold | 1,080,000 | $10.38 | $11M | — | — | |
| Holding | Hold | 1,120,102 | $9.92 | $11M | — | — | |
| TPG Pace Beneficial II | Hold | 1,116,833 | $9.78 | $11M | — | — | |
| GPOR, Gulfport Energy | Reduce −22.6% | 116,408 | $88.29 | $10M | −33,918 | −$1.7M | |
| Concord Acquisition | Hold | 1,005,100 | $10.05 | $10M | — | — | |
| NTRA, Natera | Reduce −1.1% | 227,953 | $43.82 | $10M | −2,599 | +$1.8M | |
| Holding | Hold | 1,000,000 | $9.91 | $9.9M | — | — | |
| Churchill Capital Corporation VII | Hold | 1,000,000 | $9.83 | $9.8M | — | — | |
| Forum Merger IV | Hold | 1,000,000 | $9.82 | $9.8M | — | — | |
| Churchill Capital Corporation VI | Hold | 997,767 | $9.83 | $9.8M | — | — | |
| Legend Biotech | New | 237,714 | $40.80 | $9.7M | +237,714 | +$9.7M | |
| Screaming Eagle Acquisitn | Hold | 1,000,000 | $9.68 | $9.7M | — | — | |
| CRBU, Caribou Biosciences | Reduce −59.3% | 896,369 | $10.55 | $9.5M | −1,307,526 | −$2.5M | |
| Holding | Hold | 900,000 | $10.06 | $9.1M | — | — | |
| Atento | Hold | 2,230,357 | $4.04 | $9M | — | — | |
| Interprivate II Acquisition | Hold | 882,647 | $9.84 | $8.7M | — | — | |
| RXR Acquisition | Hold | 854,961 | $9.84 | $8.4M | — | — | |
| Holding | Hold | 843,046 | $9.82 | $8.3M | — | — | |
| Holding | Hold | 835,638 | $9.89 | $8.3M | — | — | |
| Holding | Hold | 848,184 | $9.69 | $8.2M | — | — | |
| Holding | Hold | 800,000 | $9.94 | $8M | — | — | |
| Arya Sciences Acqu Corporation IV | Hold | 800,000 | $9.92 | $7.9M | — | — | |
| Levere | Hold | 800,000 | $9.90 | $7.9M | — | — | |
| Landcadia Holdings IV | Hold | 802,028 | $9.83 | $7.9M | — | — | |
| Holding | Hold | 775,200 | $9.97 | $7.7M | — | — | |
| Holding | Hold | 750,000 | $10.00 | $7.5M | — | — | |
| Pathfinder Acquisition | Hold | 750,000 | $9.94 | $7.5M | — | — | |
| Holding | Hold | 750,000 | $9.92 | $7.4M | — | — | |
| Holding | Hold | 750,000 | $9.87 | $7.4M | — | — | |
| Social Leverage Acquisn | Hold | 750,000 | $9.83 | $7.4M | — | — | |
| Research Alliance Corporation II | Hold | 750,000 | $9.82 | $7.4M | — | — | |
| Panacea Acquisition Corporation II | Hold | 750,000 | $9.80 | $7.4M | — | — | |
| Holding | Hold | 745,000 | $9.85 | $7.3M | — | — | |
| Holding | Hold | 700,000 | $9.91 | $6.9M | — | — | |
| Khosla Ventures Acquisition | Hold | 700,000 | $9.80 | $6.9M | — | — | |
| Corsair Partnering | Hold | 700,000 | $9.79 | $6.9M | — | — | |
| Gores Holdings VIII | Hold | 692,810 | $9.87 | $6.8M | — | — | |
| NUVB, Nuvation Bio | Hold | 2,900,000 | $2.24 | $6.5M | — | — | |
| Rocket Internet Grwt Oprt | Hold | 647,945 | $9.91 | $6.4M | — | — | |
| RCF Acquisition | Hold | 600,000 | $10.09 | $6.1M | — | — | |
| Holding | Hold | 600,000 | $9.85 | $5.9M | — | — | |
| Finserv Acquisition Corporation II | Hold | 600,000 | $9.84 | $5.9M | — | — | |
| Slam | Hold | 570,396 | $9.91 | $5.7M | — | — | |
| Blue Whale Acquisition | Hold | 575,000 | $9.70 | $5.6M | — | — | |
| Holding | Hold | 502,001 | $9.89 | $5M | — | — | |
| Ftac Hera Acquisition | Hold | 500,000 | $9.93 | $5M | — | — | |
| G Squared Ascend | Hold | 500,000 | $9.93 | $5M | — | — | |
| Holding | Hold | 500,000 | $9.92 | $5M | — | — | |
| Gores Holdings IX | Hold | 500,000 | $9.68 | $4.8M | — | — | |
| Ready Capital | Hold | 472,537 | $10.14 | $4.8M | — | — | |
| Holding | Hold | 484,709 | $9.79 | $4.7M | — | — | |
| VNET, Vnet Group | New | 825,000 | $5.50 | $4.5M | +825,000 | +$4.5M | |
| Scion Tech Growth II | Hold | 450,000 | $9.94 | $4.5M | — | — | |
| Holding | Hold | 452,519 | $9.83 | $4.4M | — | — | |
| LDH Growth | Hold | 436,702 | $9.91 | $4.3M | — | — | |
| SVF Investment | Hold | 425,000 | $9.96 | $4.2M | — | — | |
| VPC Impact Acquisition | Hold | 425,000 | $9.93 | $4.2M | — | — | |
| Lamf Global Ventures | Hold | 400,000 | $10.09 | $4M | — | — | |
| Holding | Hold | 400,000 | $9.84 | $3.9M | — | — | |
| Holding | Hold | 400,000 | $9.82 | $3.9M | — | — | |
| COGT, Cogent Biosciences | Reduce −75.5% | 245,139 | $14.92 | $3.7M | −754,861 | −$5.4M | |
| Cartica Acquisition | Hold | 350,000 | $10.11 | $3.5M | — | — | |
| Holding | Hold | 350,000 | $10.03 | $3.5M | — | — | |
| Uta Acquisition | Hold | 344,100 | $10.02 | $3.4M | — | — | |
| ALVO, Alvotech | Hold | 500,000 | $6.76 | $3.4M | — | — | |
| Exscientia | New | 400,000 | $8.21 | $3.3M | +400,000 | +$3.3M | |
| Sound Point Acquisition | Hold | 300,000 | $10.19 | $3.1M | — | — | |
| Holding | Hold | 300,000 | $10.09 | $3M | — | — | |
| Holding | Hold | 810,500 | $3.72 | $3M | — | — | |
| Holding | Hold | 304,698 | $9.82 | $3M | — | — | |
| Lazard Growth Acquisition | Hold | 300,000 | $9.92 | $3M | — | — | |
| Broadscale Acquisition | Hold | 250,000 | $9.85 | $2.5M | — | — | |
| Hudson Executive Inves III | Hold | 250,000 | $9.84 | $2.5M | — | — | |
| Live Oak Mobility Acquisi | Hold | 250,000 | $9.83 | $2.5M | — | — | |
| Ventyx Biosciences | Reduce −92.5% | 70,000 | $34.91 | $2.4M | −860,648 | −$8.9M | |
| Liberty Media Acquisition | Hold | 210,000 | $9.94 | $2.1M | — | — | |
| Arctos Northstar Acquis | Hold | 200,000 | $9.91 | $2M | — | — | |
| Better Therapeutics | Hold | 1,000,000 | $1.76 | $1.8M | — | — | |
| Clever Leaves | Hold | 2,466,892 | $0.6020 | $1.5M | — | — | |
| BHVN, Biohaven | New | 235,000 | $6.30 | $1.5M | +235,000 | +$1.5M | |
| Priveterra Acquisition | Hold | 150,000 | $9.85 | $1.5M | — | — | |
| Theseus Pharmaceuticals | Reduce −45.5% | 223,149 | $5.80 | $1.3M | −186,568 | −$972K | |
| Music Acquisition | Hold | 125,000 | $9.86 | $1.2M | — | — | |
| TNGX, Tango Therapeutics | Hold | 300,000 | $3.62 | $1.1M | — | — | |
| Crypto 1 Acquisition | Hold | 100,000 | $10.04 | $1M | — | — | |
| NTRS, Northern Trust | Hold | 100,000 | $9.85 | $985K | — | — | |
| NTRS, Northern Trust | Hold | 100,000 | $9.83 | $983K | — | — | |
| OKLO, Altc Acquisition | Hold | 98,300 | $9.76 | $959K | — | — | |
| Summit Midstream Partners | Hold | 43,055 | $15.03 | $647K | — | — | |
| Ion Acquisition Corporation 3 | Hold | 56,151 | $9.87 | $554K | — | — | |
| Avrobio | Hold | 740,000 | $0.6419 | $475K | — | — | |
| EDU | Hold | 13,000 | $24.00 | $312K | — | — | |
| Holding | Hold | 85,838 | $3.29 | $282K | — | — |
Showing top 50 of 191 by value
Exits / last held
Gone since 2022 Q2, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| COHR, Coherent | Exit | 0 | $266.22 | $154M | −577,982 | −$154M | |
| TSM, Taiwan Semiconductor | Exit | 0 | $81.75 | $92M | −1,126,125 | −$92M | |
| Blueprint Medicines | Exit | 0 | $50.51 | $61M | −1,211,987 | −$61M | |
| IOVA, Iovance Biotherapeutics | Exit | 0 | $11.04 | $35M | −3,176,773 | −$35M | |
| Vonage | Exit | 0 | $18.84 | $33M | −1,727,000 | −$33M | |
| Holding | Exit | 0 | $19.97 | $27M | −1,350,500 | −$27M | |
| NVAX, Novavax | Exit | 0 | $51.43 | $26M | −498,000 | −$26M | |
| Radius Health | Exit | 0 | $10.37 | $22M | −2,107,400 | −$22M | |
| Sanderson Farms | Exit | 0 | $215.52 | $17M | −80,000 | −$17M | |
| Healthcare Trust Amer | Exit | 0 | $27.91 | $14M | −500,000 | −$14M | |
| Holding | Exit | 0 | $9.95 | $9.8M | −985,300 | −$9.8M | |
| CDK Global | Exit | 0 | $54.77 | $5.8M | −106,514 | −$5.8M | |
| QTRX, Quanterix | Exit | 0 | $16.19 | $4.2M | −260,000 | −$4.2M | |
| RCEL, Avita Medical | Exit | 0 | $4.75 | $2.8M | −580,000 | −$2.8M | |
| Ikena Oncology | Exit | 0 | $4.43 | $1.3M | −290,000 | −$1.3M | |
| Lianbio | Exit | 0 | $2.16 | $1.1M | −500,000 | −$1.1M | |
| ANNX, Annexon | Exit | 0 | $3.77 | $490K | −130,000 | −$490K |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
Farallon Capital Management, L.l.c.
87 processed 13Fs on this site, 2021 Q3 to 2026 Q2